Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia

High-Density Lipoprotein Particle Size and Concentration and Coronary Risk

(2013) Karim El Harchaoui   ANNALS OF INTERNAL MEDICINE

Lipids and Lipoproteins and Risk of Different Vascular Events in the MRC/BHF Heart Protection Study

(2012) Sarah Parish et al.   CIRCULATION

High-Density Lipoprotein Cholesterol and Particle Concentrations, Carotid Atherosclerosis, and Coronary Events

(2012) Rachel H. Mackey et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Subclass Abnormalities and Incident Hypertension in Initially Healthy Women

(2011) N. P. Paynter et al.   CLINICAL CHEMISTRY

Underappreciated opportunities for low-density lipoprotein management in patients with cardiometabolic residual risk

(2010) Robert S. Rosenson et al.   ATHEROSCLEROSIS

Lipoprotein Particle Size and Concentration by Nuclear Magnetic Resonance and Incident Type 2 Diabetes in Women

(2010) S. Mora et al.   DIABETES

Initial Combination Therapy With Metformin and Colesevelam for Achievement of Glycemic and Lipid Goals in Early Type 2 Diabetes

(2010) Julio Rosenstock et al.   Endocrine Practice

Colesevelam Hydrochloride to Treat Hypercholesterolemia and Improve Glycemia in Prediabetes: A Randomized, Prospective Study

(2010) Yehuda Handelsman et al.   Endocrine Practice

Pre-Diabetes and the Risk for Cardiovascular Disease

(2010) Earl S. Ford et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Lipoprotein Particle Profiles by Nuclear Magnetic Resonance Compared With Standard Lipids and Apolipoproteins in Predicting Incident Cardiovascular Disease in Women

(2009) Samia Mora et al.   CIRCULATION

Rationale and design of a clinical trial to evaluate metformin and colesevelam HCl as first-line therapy in type 2 diabetes and colesevelam HCl in prediabetes

(2009) Michael R. Jones et al.   CURRENT MEDICAL RESEARCH AND OPINION

Colesevelam HCl effects on atherogenic lipoprotein subclasses in subjects with type 2 diabetes

(2008) Robert S. Rosenson et al.   ATHEROSCLEROSIS

Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome

(2008) Manfredi Rizzo et al.   CLINICAL ENDOCRINOLOGY

Lipoprotein Management in Patients With Cardiometabolic Risk: Consensus statement from the American Diabetes Association and the American College of Cardiology Foundation

(2008) J. D. Brunzell et al.   DIABETES CARE